Ingevity posts Q3 2026 results with lower sales but higher profit and raises full‑year outlook
Ingevity reported third‑quarter 2026 net sales of $305.1 million, an 8% decline year‑over‑year, while net income rose to $51.1 million, or $1.46 per diluted share. Adjusted EBITDA fell to $108 million, but the margin expanded to 35.4%. The company narrowed its full‑year adjusted EBITDA guidance to $385 million‑$395 million and forecast FY 2026 EPS of $5.25‑$5.45 on revenue of about $1.10 billion. It also repurchased $39 million of its own shares during the quarter.
Why it matters
The company’s FY 2026 EPS guidance of $5.25‑$5.45 and revenue target of $1.10 billion set expectations for earnings growth and cash flow generation. The $39 million share repurchase reflects continued capital return to shareholders.
Key facts
- 1Net sales were $305.1 million, down 8% from the prior year. stocktitan.net
- 2Net income from continuing operations was $51.1 million, or $1.46 per diluted share. sec.gov
- 3Adjusted EBITDA from continuing operations was $108.0 million, down $2.4 million, with a margin of 35.4%. sec.gov
- 4Full‑year adjusted EBITDA outlook was narrowed to a range of $385 million to $395 million. sec.gov
- 5Adjusted earnings per share was $1.63, up from $1.31 in the prior year quarter. finance.yahoo.com
- 6FY 2026 EPS guidance is $5.25‑$5.45 and revenue guidance is $1.10 billion. investing.com
Summary written by AlphAI AI Desk from 5 of 5 sources. Not investment advice. Figures are as stated by the linked sources.